Nov 25, 2025 8:30 am EST LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
Oct 29, 2025 8:00 am EDT LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3
